APOA1 and diabetes mellitus: As the accumulation of oxidised LDLs in the artery wall is a key event in atherosclerotic lesion development, it follows that nonenzymatically glycated apoA-I may contribute indirectly to the accelerated atherosclerotic lesion development that occurs in diabetes [120].